MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 Post date April 25, 2025 ← MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates → MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update
